Asiri Surgical Hospital 미래 성장

Future 기준 확인 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Asiri Surgical Hospital.

주요 정보

n/a

수익 성장률

n/a

EPS 성장률

Healthcare 수익 성장	18.8%
매출 성장률	n/a
향후 자기자본 수익률	n/a
애널리스트 커버리지	None
마지막 업데이트	n/a

최근 미래 성장 업데이트

업데이트 없음

Recent updates

이 섹션에서는 일반적으로 투자자가 회사의 수익 창출 능력을 이해하는 데 도움이 되도록 전문 애널리스트의 컨센서스 추정치를 기반으로 수익 및 수익 성장 전망치를 제시합니다. 하지만 Asiri Surgical Hospital 은 충분한 과거 데이터를 제공하지 않았고 애널리스트 예측도 없기 때문에 과거 데이터를 추정하거나 애널리스트 예측을 사용하여 미래 수익을 안정적으로 계산할 수 없습니다.

SimplyWall St에서 다루는 기업의 97%가 과거 재무 데이터를 가지고 있기 때문에 이는 매우 드문 상황입니다.

수익 및 매출 성장 예측

COSE:AMSL.N0000 - 애널리스트의 미래 추정치 및 과거 재무 데이터 (LKR Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
6/30/2024	6,645	555	-309	-145	N/A
3/31/2024	6,620	655	99	246	N/A
12/31/2023	6,544	497	509	680	N/A
9/30/2023	6,379	574	281	486	N/A
6/30/2023	6,086	600	316	572	N/A
3/31/2023	5,635	555	248	571	N/A
12/31/2022	5,586	823	458	819	N/A
9/30/2022	5,774	1,040	887	1,223	N/A
6/30/2022	5,793	1,126	739	1,059	N/A
3/31/2022	5,838	1,185	863	1,129	N/A
12/31/2021	5,588	1,112	959	1,164	N/A
9/30/2021	5,120	1,180	552	718	N/A
6/30/2021	4,848	1,074	609	758	N/A
3/31/2021	4,230	822	432	638	N/A
12/31/2020	3,835	676	313	538	N/A
9/30/2020	3,632	302	614	884	N/A
6/30/2020	3,446	308	303	573	N/A
3/31/2020	3,655	433	58	294	N/A
12/31/2019	3,688	457	77	401	N/A
9/30/2019	3,623	464	-164	358	N/A
6/30/2019	3,546	390	-82	532	N/A
3/31/2019	3,475	367	-30	648	N/A
12/31/2018	3,390	304	204	833	N/A
9/30/2018	3,321	334	295	802	N/A
6/30/2018	3,251	517	371	833	N/A
3/31/2018	3,275	547	N/A	884	N/A
12/31/2017	3,232	564	N/A	823	N/A
9/30/2017	3,140	511	N/A	546	N/A
6/30/2017	3,039	304	N/A	470	N/A
3/31/2017	2,884	263	N/A	556	N/A
12/31/2016	2,875	293	N/A	237	N/A
9/30/2016	2,880	337	N/A	416	N/A
6/30/2016	2,890	370	N/A	424	N/A
3/31/2016	2,922	416	N/A	301	N/A
12/31/2015	2,830	408	N/A	584	N/A
9/30/2015	2,730	379	N/A	502	N/A
6/30/2015	2,684	412	N/A	694	N/A
3/31/2015	2,654	408	N/A	762	N/A
12/31/2014	2,651	453	N/A	676	N/A
9/30/2014	2,618	476	N/A	653	N/A
6/30/2014	2,340	447	N/A	493	N/A
3/31/2014	2,508	473	N/A	549	N/A
12/31/2013	2,397	-338	N/A	355	N/A

애널리스트 미래 성장 예측

수입 대 저축률: Insufficient data to determine if AMSL.N0000's forecast earnings growth is above the savings rate (3.7%).

수익 vs 시장: Insufficient data to determine if AMSL.N0000's earnings are forecast to grow faster than the LK market

고성장 수익: Insufficient data to determine if AMSL.N0000's earnings are expected to grow significantly over the next 3 years.

수익 대 시장: Insufficient data to determine if AMSL.N0000's revenue is forecast to grow faster than the LK market.

고성장 수익: Insufficient data to determine if AMSL.N0000's revenue is forecast to grow faster than 20% per year.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: Insufficient data to determine if AMSL.N0000's Return on Equity is forecast to be high in 3 years time

Asiri Surgical Hospital 미래 성장

Future 기준 확인 0/6

주요 정보

최근 미래 성장 업데이트

Recent updates

Less than half of directors are independent

Asiri Surgical Hospital plc Announces Retirement of Mr. Gardiya Lokuge Harris Premaratne as Director

New minor risk - Dividend sustainability

Upcoming dividend of LK₨0.30 per share

Asiri Surgical Hospital PLC, Annual General Meeting, Sep 30, 2024

First quarter 2025 earnings released: EPS: LK₨0.29 (vs LK₨0.36 in 1Q 2024)

New minor risk - Share price stability

Full year 2024 earnings released: EPS: LK₨1.12 (vs LK₨1.05 in FY 2023)

Third quarter 2024 earnings released: EPS: LK₨0.22 (vs LK₨0.36 in 3Q 2023)

New minor risk - Share price stability

Asiri Surgical Hospital plc Appoints Dr. Sivakumar Selliah as Senior Independent Director

Asiri Surgical Hospital plc Appoints Dr. Sivakumar Selliah as Senior Independent Director

Second quarter 2024 earnings released: EPS: LK₨0.28 (vs LK₨0.33 in 2Q 2023)

Asiri Surgical Hospital PLC, Annual General Meeting, Sep 25, 2023

Insufficient new directors

First quarter 2024 earnings released: EPS: LK₨0.36 (vs LK₨0.27 in 1Q 2023)

New minor risk - Profit margin trend

Full year 2023 earnings released: EPS: LK₨1.04 (vs LK₨2.24 in FY 2022)

Third quarter 2023 earnings released: EPS: LK₨0.36 (vs LK₨0.78 in 3Q 2022)

Investor sentiment improved over the past week

Second quarter 2023 earnings released: EPS: LK₨0.33 (vs LK₨0.49 in 2Q 2022)

Now 21% undervalued after recent price drop

Asiri Surgical Hospital PLC, Annual General Meeting, Aug 19, 2022

Full year 2022 earnings released: EPS: LK₨2.25 (vs LK₨1.56 in FY 2021)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Upcoming dividend of LK₨0.90 per share

Investor sentiment improved over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Inaugural dividend of LK₨1.20 per share

Second quarter 2022 earnings released: EPS LK₨0.49 (vs LK₨0.29 in 2Q 2021)

First quarter 2022 earnings released: EPS LK₨0.38 (vs LK₨0.093 loss in 1Q 2021)

New 90-day low: LK₨13.20

Investor sentiment improved over the past week

Market bids up stock over the past week

New 90-day high: LK₨14.50

First half earnings released

New 90-day high: LK₨13.00

New 90-day high - LK₨10.60

First quarter earnings released

수익 및 매출 성장 예측

애널리스트 미래 성장 예측

주당 순이익 성장 예측

미래 자기자본 수익률

성장 기업 발견